Capital Markets Trading (UK)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$555K Buy
+19,767
New +$526K 0.01% 268
2025
Q3
Sell
-11,667
Closed -$288K 311
2025
Q2
$283K Sell
11,667
-9,612
-45% -$224K ﹤0.01% 265
2025
Q1
$539K Sell
21,279
-154,847
-88% -$4.05M 0.01% 262
2024
Q4
$4.67M Buy
176,126
+56,350
+47% +$1.53M 0.07% 159
2024
Q3
$3.47M Buy
119,776
+19,862
+20% +$579K 0.05% 172
2024
Q2
$2.8M Buy
99,914
+57,923
+138% +$1.59M 0.04% 182
2024
Q1
$1.17M Buy
41,991
+34,577
+466% +$959K 0.02% 230
2023
Q4
$213K Buy
+7,414
New +$224K ﹤0.01% 261
2021
Q3
Sell
-7,091
Closed -$314K 247
2021
Q2
$278K Buy
+7,091
New +$276K ﹤0.01% 189
2020
Q4
Sell
-37,633
Closed -$1.38M 219
2020
Q3
$1.35M Buy
37,633
+30,739
+446% +$1.08M 0.02% 151
2020
Q2
$214K Sell
6,894
-22,498
-77% -$764K 0.01% 178
2020
Q1
$910K Buy
29,392
+4,546
+18% +$155K 0.02% 170
2019
Q4
$924K Sell
24,846
-15,152
-38% -$540K 0.04% 145
2019
Q3
$1.36M Buy
39,998
+32,895
+463% +$1.2M 0.06% 143
2019
Q2
$292K Buy
7,103
+2,673
+60% +$106K 0.01% 191
2019
Q1
$179K Buy
+4,430
New +$177K 0.01% 170
2018
Q2
Sell
-7,357
Closed -$251K 191
2018
Q1
$248K Buy
+7,357
New +$253K 0.01% 172

Other funds holding PFE

Capital Markets Trading (UK)'s PFE Position: Q1 2026 in Review

Capital Markets Trading (UK) opened a new position in Pfizer (PFE) in Q1 2026: 19,767 shares worth $555K. The stake represents 0.01% of the portfolio and ranks #268 among its holdings. This is a return to the name: Capital Markets Trading (UK) previously reported a position in PFE as recently as Q2 2025.

Capital Markets Trading (UK) first reported a position in PFE in Q1 2018 and has held it in 17 quarters since. The position peaked at $4.67M in Q4 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Capital Markets Trading (UK) held 19,767 shares of Pfizer worth $555K as of Q1 2026.
  • Pfizer was a new Capital Markets Trading (UK) position in Q1 2026.
  • Pfizer made up 0.01% of Capital Markets Trading (UK)'s portfolio in Q1 2026, its #268 holding.
  • Capital Markets Trading (UK) first reported a position in Pfizer in Q1 2018 and has held it in 17 quarters since.
  • Capital Markets Trading (UK)'s Pfizer position peaked at $4.67M in Q4 2024.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Capital Markets Trading (UK)'s 13F filing for Q1 2026, filed 15 May 2026.